An Economic Framework for Evaluating Biomarkers Used to Target CVD Prevention

“Heart scans” for coronary calcium and other newly discovered tests (“biomarkers”) can help identify persons at risk for heart attacks and stroke who should be treated with medications to lower their risk. By estimating how many heart attacks, strokes and deaths could be prevented by using these tests routinely in the U.S. and how much money this would cost, our study will help policymakers decide when doctors should order a heart scan or other biomarker test.

Principal Investigator/Fellow: Mark Pletcher